Colin Smith Mackay
Directeur Général chez Symbiosis Pharmaceutical Services Ltd.
Profil
Colin Smith Mackay has held positions as Chief Executive Officer at Symbiosis Pharmaceutical Services Ltd.
and Director at Symbiosis Holdings (Scotland) Ltd.
Postes actifs de Colin Smith Mackay
| Sociétés | Poste | Début |
|---|---|---|
Symbiosis Pharmaceutical Services Ltd.
 Symbiosis Pharmaceutical Services Ltd. Pharmaceuticals: MajorHealth Technology Symbiosis Pharmaceutical Services Ltd. is a pharmaceutical contract development and manufacturing organization established in 2011 in Scotland. The British company specializes in providing niche sterile manufacturing services to GMP standards and producing injectable products for its clients to use in their clinical trials or to supply specialist commercial markets. Symbiosis Pharma has a manufacturing facility that can manufacture biologic, vaccine, or small-molecule sterile bio/pharmaceutical products for biotechnology and pharmaceutical clients who are developing medicines to treat cancers and neurodegenerative diseases. The CEO of the private company is Colin Smith Mackay. | Directeur Général | - |
Symbiosis Holdings (Scotland) Ltd.
 Symbiosis Holdings (Scotland) Ltd. Financial ConglomeratesFinance Symbiosis Holdings (Scotland) Ltd. is an investment holding British company founded in 2020. The private company is based in Stirling, UK. | Directeur/Membre du Conseil | 04/03/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Symbiosis Pharmaceutical Services Ltd.
Symbiosis Pharmaceutical Services Ltd. Pharmaceuticals: MajorHealth Technology Symbiosis Pharmaceutical Services Ltd. is a pharmaceutical contract development and manufacturing organization established in 2011 in Scotland. The British company specializes in providing niche sterile manufacturing services to GMP standards and producing injectable products for its clients to use in their clinical trials or to supply specialist commercial markets. Symbiosis Pharma has a manufacturing facility that can manufacture biologic, vaccine, or small-molecule sterile bio/pharmaceutical products for biotechnology and pharmaceutical clients who are developing medicines to treat cancers and neurodegenerative diseases. The CEO of the private company is Colin Smith Mackay. | Health Technology |
Symbiosis Holdings (Scotland) Ltd.
Symbiosis Holdings (Scotland) Ltd. Financial ConglomeratesFinance Symbiosis Holdings (Scotland) Ltd. is an investment holding British company founded in 2020. The private company is based in Stirling, UK. | Finance |
